RESOLVE: letRozole abEmaciclib combinationS in endOmetriaL and oVarian cancEr: A Multi-Cohort Phase 2 Study of Letrozole/Abemaciclib Alone and in Combination With Metformin, Zotatifin and Gedatolisib
Latest Information Update: 20 Jun 2025
At a glance
- Drugs Abemaciclib (Primary) ; Gedatolisib (Primary) ; Letrozole (Primary) ; Metformin (Primary) ; Samotolisib (Primary)
- Indications Adenocarcinoma; Endometrial cancer
- Focus Therapeutic Use
- Acronyms RESOLVE
Most Recent Events
- 15 Jun 2025 Planned number of patients changed from 130 to 180.
- 15 Jun 2025 Planned End Date changed from 1 Aug 2030 to 1 Aug 2031.
- 15 Jun 2025 Planned primary completion date changed from 1 Aug 2027 to 1 Aug 2028.